NUVATION BIO INC (NUVB) Stock Earnings & Estimates
NYSE:NUVB - US67080N1019 - Common Stock
2.9 USD
+0.16 (+5.84%)
2.9 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.873M | 15.65M 98.78% | 92.289M 489.71% | 152.9M 65.68% | 401.34M 162.49% | 520.79M 29.76% | 686.53M 31.82% | 813.39M 18.48% | 979.49M 20.42% | |||
| EBITDA YoY % growth | -112.13M -20.39% | -99.6M 11.17% | -166.874M -67.54% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -112.33M -20.37% | -99.822M 11.14% | -167.557M -67.86% | -248.622M -48.38% | -223.885M 9.95% | -211.197M 5.67% | -62.78M 70.27% | 58.81M 193.68% | 167.94M 185.56% | 265.04M 57.82% | 396.46M 49.58% | |
| Operating Margin | N/A | N/A | -2,128.25% | -1,588.64% | -242.59% | -138.13% | -15.64% | 11.29% | 24.46% | 32.58% | 40.48% | |
| EPS YoY % growth | -0.48 -9.09% | -0.34 29.17% | -0.52 -52.94% | -0.68 -30.39% | -0.64 6.32% | -0.58 8.75% | 0.06 110.56% | 3.43 5,500.00% | -0.23 -106.85% | 0.17 173.91% | 0.59 241.18% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.17 -16.48% | -0.15 -2.48% | -0.17 -6.30% |
| Revenue Q2Q % growth | 5.391M 641.54% | 11M 92.61% | 17.082M 453.89% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -62.898M -30.76% | -62.356M -15.60% | -53.001M 10.17% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.17 -13.33% | -0.17 | 0.00 | 0.88% |
| Q1 2025 Q2Q % growth | -0.16 -128.57% | -0.16 | 0.00 | 0.90% |
| Q4 2024 Q2Q % growth | -0.15 -150.00% | -0.14 | -0.01 | -6.56% |
| Q3 2024 Q2Q % growth | -0.15 -66.67% | -0.13 | -0.02 | -13.12% |
| Q2 2024 Q2Q % growth | -0.15 -66.67% | -0.06 | -0.09 | -151.38% |
| Q1 2024 Q2Q % growth | -0.07 30.00% | -0.10 | 0.03 | 28.36% |
| Q4 2023 Q2Q % growth | -0.06 40.00% | -0.11 | 0.05 | 43.89% |
| Q3 2023 Q2Q % growth | -0.09 25.00% | -0.11 | 0.02 | 19.54% |
| Q2 2023 Q2Q % growth | -0.09 43.75% | -0.11 | 0.02 | 21.10% |
| Q1 2023 Q2Q % growth | -0.10 | -0.10 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.10 16.67% | -0.12 | 0.02 | 14.75% |
| Q3 2022 Q2Q % growth | -0.12 -9.09% | -0.14 | 0.02 | 15.97% |
| Q2 2022 Q2Q % growth | -0.16 -77.78% | -0.14 | -0.02 | -18.07% |
| Q1 2022 Q2Q % growth | -0.10 16.67% | -0.15 | 0.05 | 31.92% |
| Q4 2021 Q2Q % growth | -0.12 -152.08% | -0.12 | 0.00 | 0.58% |
| Q3 2021 Q2Q % growth | -0.11 | -0.11 | 0.00 | -1.74% |
| Q2 2021 Q2Q % growth | -0.09 | -0.10 | 0.01 | 9.96% |
| Q1 2021 Q2Q % growth | -0.12 | -0.07 | -0.05 | -68.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.833M 236.79% | 364.283K | 4.469M | 1,226.72% |
| Q1 2025 Q2Q % growth | 3.084M | 425.003K | 2.659M | 625.64% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0.43% |
| Revenue | 0% | 0% | 0% | 1.8% |